Related Experiment Video
Updated: Feb 24, 2026
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Telocytes - a Hope for Cardiac Repair after Myocardial Infarction
Ruxandra Dragoi Galrinho1, Catalin Gabriel Manole2, Dragos Vinereanu3
1"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania ; University and Emergency Hospital, Bucharest, Romania ; "Victor Babes" National Institute of Research Development in the Pathology Domain and Biomedical Sciences, Bucharest, Romania.
Insights
Telocytes (TCs) show potential for regenerating heart tissue after myocardial infarction. Further research into TCs could lead to new therapeutic strategies for cardiovascular disease.
Area of Science:
- Cardiology
- Regenerative Medicine
- Cell Biology
Background:
- Cardiovascular diseases, especially myocardial infarction, are a major global health concern.
- Current pharmacological and interventional therapies have limitations.
- Cell-based therapies for myocardial infarction have shown inconsistent clinical efficacy.
Purpose of the Study:
- To review the characteristics and functions of telocytes (TCs).
- To explore the potential of TCs in cardiac repair and regeneration.
- To identify novel therapeutic targets for myocardial infarction.
Main Methods:
- Literature review of telocyte characteristics and functions.
- Analysis of existing research on cell-based therapies for myocardial infarction.
- Evaluation of evidence for TCs in cardiac regeneration.
Main Results:
- Telocytes (TCs) are a recently identified type of interstitial cell.
- TCs possess characteristics suggesting a role in tissue repair.
- Evidence supports the potential of TCs in cardiac regeneration.
Conclusions:
- Telocytes (TCs) represent a promising novel cell type for myocardial regeneration.
- TCs may offer a new therapeutic avenue for treating myocardial infarction.
- Targeting telocytes could advance regenerative strategies for heart repair.
Abstract:
Cardiovascular diseases, particularly myocardial infarction, remain the leading cause of morbidity and mortality worldwide, even though pharmacological and interventional therapies improved significantly in the last years. Moreover, despite encouraging results of cell - based therapies in experimental myocardial infarction models, clinical trials showed inconsistent and modest efficiency. Therefore the next step should be the revealing of a new cell type, capable of regenerating the damaged myocardium. Telocytes (TCs), a relatively new type of interstitial cells, were described few years ago and are credited with important roles in regenerative therapies. In this paper we review their most important characteristics and functions, showing the evidences of their potential role in cardiac repair and regeneration. Our research leads to the conclusion that TCs might be a novel target for therapeutic strategies in myocardial infarction.
